The Cigna Group (NYSE:CI) Shares Sold by Metis Global Partners LLC

Metis Global Partners LLC cut its stake in The Cigna Group (NYSE:CI) by 5.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,171 shares of the health services provider’s stock after selling 670 shares during the period. Metis Global Partners LLC’s holdings in The Cigna Group were worth $3,645,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of CI. Avidian Wealth Solutions LLC raised its stake in shares of The Cigna Group by 3.1% in the fourth quarter. Avidian Wealth Solutions LLC now owns 2,401 shares of the health services provider’s stock worth $719,000 after purchasing an additional 73 shares during the last quarter. Measured Wealth Private Client Group LLC increased its holdings in The Cigna Group by 7.5% in the 4th quarter. Measured Wealth Private Client Group LLC now owns 1,714 shares of the health services provider’s stock worth $513,000 after buying an additional 119 shares during the period. FourThought Financial Partners LLC raised its position in The Cigna Group by 6.3% during the 4th quarter. FourThought Financial Partners LLC now owns 1,787 shares of the health services provider’s stock worth $535,000 after buying an additional 106 shares during the last quarter. TCG Advisory Services LLC acquired a new stake in The Cigna Group during the 4th quarter valued at approximately $542,000. Finally, Vestmark Advisory Solutions Inc. purchased a new stake in shares of The Cigna Group in the 4th quarter valued at $1,218,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling

In other news, CEO David Cordani sold 31,209 shares of the firm’s stock in a transaction on Monday, March 25th. The shares were sold at an average price of $355.17, for a total value of $11,084,500.53. Following the sale, the chief executive officer now directly owns 348,054 shares in the company, valued at approximately $123,618,339.18. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO David Cordani sold 31,209 shares of the stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $355.17, for a total value of $11,084,500.53. Following the transaction, the chief executive officer now owns 348,054 shares in the company, valued at approximately $123,618,339.18. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Eric P. Palmer sold 6,083 shares of the business’s stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $340.00, for a total value of $2,068,220.00. Following the sale, the insider now owns 44,649 shares of the company’s stock, valued at approximately $15,180,660. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 114,144 shares of company stock worth $39,296,330. Company insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

CI has been the subject of a number of analyst reports. Barclays assumed coverage on The Cigna Group in a report on Wednesday, March 6th. They issued an “overweight” rating and a $393.00 price target for the company. Cantor Fitzgerald increased their price target on shares of The Cigna Group from $384.00 to $400.00 and gave the stock an “overweight” rating in a report on Friday. Deutsche Bank Aktiengesellschaft raised shares of The Cigna Group from a “hold” rating to a “buy” rating and lifted their price objective for the company from $355.00 to $370.00 in a report on Thursday, February 1st. Oppenheimer increased their target price on shares of The Cigna Group from $370.00 to $400.00 and gave the stock an “outperform” rating in a research note on Friday. Finally, Wells Fargo & Company upped their price target on The Cigna Group from $334.00 to $348.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 6th. Two equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $366.14.

The Cigna Group Trading Up 0.3 %

NYSE CI traded up $0.91 on Monday, reaching $342.41. The stock had a trading volume of 1,320,047 shares, compared to its average volume of 1,590,146. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.75. The stock has a fifty day moving average price of $350.77 and a two-hundred day moving average price of $319.71. The Cigna Group has a 12-month low of $240.50 and a 12-month high of $365.71. The firm has a market capitalization of $97.27 billion, a price-to-earnings ratio of 28.04, a P/E/G ratio of 1.04 and a beta of 0.57.

The Cigna Group (NYSE:CI) last released its earnings results on Thursday, May 2nd. The health services provider reported $6.47 earnings per share for the quarter, beating the consensus estimate of $6.17 by $0.30. The Cigna Group had a return on equity of 17.24% and a net margin of 1.76%. The company had revenue of $57.25 billion during the quarter, compared to the consensus estimate of $56.59 billion. During the same period in the previous year, the company posted $5.41 EPS. The Cigna Group’s revenue was up 23.2% compared to the same quarter last year. As a group, sell-side analysts forecast that The Cigna Group will post 28.45 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 20th. Stockholders of record on Tuesday, June 4th will be paid a $1.40 dividend. This represents a $5.60 annualized dividend and a dividend yield of 1.64%. The ex-dividend date of this dividend is Tuesday, June 4th. The Cigna Group’s payout ratio is presently 45.98%.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.